Koji Sakuraya Selected Research

Messenger RNA (mRNA)

1/2014

Synergistic protective effects of mizoribine and angiotensin II receptor blockade on cyclosporine A nephropathy in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koji Sakuraya Research Topics

Disease

13	Nephrotic Syndrome (Syndrome, Nephrotic) 10/2023 - 04/2015
4	Proteinuria 05/2022 - 01/2017
3	Disease Progression 10/2023 - 02/2019
3	Fibrosis (Cirrhosis) 01/2022 - 01/2014
2	Ureteral Obstruction 01/2022 - 04/2014
2	IGA Glomerulonephritis (IGA Nephropathy) 01/2020 - 10/2018
1	Chronic Renal Insufficiency 01/2022
1	Pierson syndrome 01/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021
1	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 11/2020
1	Hematuria 01/2020
1	Nephritis 01/2020
1	Purpura 01/2020
1	Fever (Fevers) 05/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Neutropenia 06/2016
1	Infections 06/2016
1	Agammaglobulinemia (Hypogammaglobulinemia) 06/2016
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 05/2016
1	Weight Gain 05/2016
1	Birth Weight (Birth Weights) 12/2015
1	Inflammation (Inflammations) 04/2014

Drug/Important Bio-Agent (IBA)

7	Rituximab (Mabthera)FDA Link 10/2023 - 04/2015
7	SteroidsIBA 10/2023 - 01/2017
5	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2023 - 01/2014
4	Prednisolone (Predate)FDA LinkGeneric 01/2020 - 08/2017
3	Immunosuppressive Agents (Immunosuppressants)IBA 10/2023 - 01/2017
3	mizoribineIBA 01/2022 - 04/2014
2	CreatinineIBA 05/2022 - 12/2015
2	Proteins (Proteins, Gene)FDA Link 05/2022 - 12/2015
2	Methylprednisolone FDA LinkGeneric 01/2020 - 10/2018
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2018 - 04/2015
1	HydrogenIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Laminin (Merosin)IBA 01/2021
1	Erythrocyte Anion Exchange Protein 1 (Band 3 Protein)IBA 11/2020
1	dirhodium tetraacetate (DRTA)IBA 11/2020
1	Chloride-Bicarbonate AntiportersIBA 11/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2019
1	AntigensIBA 01/2019
1	ofatumumab FDA Link 01/2018
1	AntibodiesIBA 01/2018
1	Immunoglobulin G (IgG)IBA 06/2016
1	Insulin-Like Growth Factor Binding Protein 3IBA 05/2016
1	Insulin-Like Growth Factor I (IGF-1)IBA 05/2016
1	Renin InhibitorsIBA 04/2014
1	aliskiren FDA Link 04/2014
1	Messenger RNA (mRNA)IBA 01/2014

Therapy/Procedure

6	Therapeutics 01/2020 - 04/2014
2	Tonsillectomy 01/2020 - 10/2018
1	Continuous Passive Motion Therapy 02/2019
1	Ligation 05/2016
1	Aftercare (After-Treatment) 05/2016